Drug Information Related to Pancrecarb
01. Digestive Care, Inc. Announces the Filing of the First Module of NDA ....
BETHLEHEM, Pa., July 7 /PRNewswire/ -- Digestive Care, Inc. (DCI) announced today that it has submitted the first module of its New Drug Application ("NDA") for PANCRECARB(R) (pancrelipase), used in the treatment of Exocrine Pancreatic Insufficiency ("...


